HomePiflufolastat F 18Piflufolastat F 18 + Steroid Therapy

Does Piflufolastat F 18 Interact with Steroid Therapy?

Piflufolastat F 18 and Steroid Therapy have a unknown drug interaction according to U.S. FDA drug labeling data. May result in changes in uptake of PIFLUFOLASTAT F-18 in prostate cancer. Effect on PET performance not established. The mechanism involves alteration of androgen pathway affecting tracer uptake. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Unknown
Piflufolastat F 18 Class
Radioactive Diagnostic Agent
Management
Consult your pharmacist
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Piflufolastat F 18 and Steroid Therapy occurs because alteration of androgen pathway affecting tracer uptake. Clinically, this means may result in changes in uptake of piflufolastat f-18 in prostate cancer. effect on pet performance not established.

What To Tell Your Doctor or Pharmacist

If you are taking Piflufolastat F 18 and your doctor is considering prescribing Steroid Therapy (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Piflufolastat F 18(Pylarify)+💊 Steroid Therapy(Monistat Simple Therapy)

Severity & Interaction Details

ℹ️
unknown
Interaction documented — severity unclassified
The FDA label notes an interaction but the severity is not classified in our dataset.
Severity scale
MinorContra
On record
Yes
Drug A class
Radioactive Diagnostic Agent
Drug B class
Source
NLP:piflufolastat f-18

What this means in plain English

May result in changes in uptake of PIFLUFOLASTAT F-18 in prostate cancer. Effect on PET performance not established.

About Piflufolastat F 18 and Steroid Therapy

Piflufolastat F 18 is a Radioactive Diagnostic Agent. Piflufolastat F 18 is also sold under the brand name Pylarify. Piflufolastat F 18 is given by intravenous (IV) infusion.

What the FDA label says

"Alteration of androgen pathway affecting tracer uptake"

📖 Source: NLP:piflufolastat f-18

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Piflufolastat F 18 and Steroid Therapy against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.